Surfactant protein gene expressions for detection of lung carcinoma cells in peripheral blood.

BACKGROUND Inflow of tumor cells to circulation is an essential step for metastasis of primary tumors. To know its state may contribute to therapeutic strategy. However, methodology to detect lung carcinoma cells floating in peripheral blood has not been established. Pulmonary surfactant protein (SP)-A, SP-C and Clara cells-10 kd protein (CC10) are specific to the lung and often expressed in primary lung carcinomas. We evaluated the worth of these gene expressions for the detection of carcinoma cells in peripheral blood. METHODS The expressions in 5 ml of venous blood were tested by RT-PCR. Ninety-nine patients with non-small cell lung carcinoma (NSCLC) and 17 with small cell lung carcinoma (SCLC) were compared to 13 with secondary lung tumor, 48 with non-malignant respiratory diseases and 19 healthy volunteers. RESULTS The mRNA expressions of SP-A and SP-C were completely specific to NSCLC when compared to SCLC and secondary lung tumors. All of the healthy volunteers and patients with non-malignant respiratory diseases showed negative for these mRNA expressions, except for one sample. The positive rate of SP-A, SP-C and CC10 mRNA in patients with NSCLC was 33.3%, 14.1%, 3.3%, respectively. The rates of SP-A and SP-C mRNA were higher than that (11.1%) in CEA mRNA. The increased positive rate of mRNA of SP-A and SP-C was significantly dependent on the clinical stage and the existence of distant metastasis. CONCLUSION These results demonstrate that the detection of mRNA of SP-A and SP-C would give clinicians valuable information suggesting the presence of blood-floating carcinoma cells as a step toward metastasis.

[1]  M. Ogawa,et al.  Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. , 1999, Surgery.

[2]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[3]  G. Castaldo,et al.  Lung cancer metastatic cells detected in blood by reverse transcriptase-polymerase chain reaction and dot-blot analysis. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. Hovig,et al.  Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells , 1999, International journal of cancer.

[5]  W. Zimmermann,et al.  A polymerase‐chain‐reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)‐gene‐family members , 1993, International journal of cancer.

[6]  M. Ogawa,et al.  A pulmonary metastatic model of human non-small cell lung carcinoma cells that produce a neutrophil elastase-like molecule in severe combined immunodeficiency mice. , 2003, Chest.

[7]  L. Liotta,et al.  The significance of hematogenous tumor cell clumps in the metastatic process. , 1976, Cancer research.

[8]  A. Nicholson,et al.  The value of PE‐10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumours , 1995, Histopathology.

[9]  W. Zimmermann,et al.  Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression , 1990, Molecular and cellular biology.

[10]  K. Shirato,et al.  Detection of surfactant protein-A gene transcript in the cells from pleural effusion for the diagnosis of lung adenocarcinoma. , 1997, The American journal of medicine.

[11]  K. Fujimori,et al.  Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. , 1987, Cancer research.

[12]  S. Steinberg,et al.  Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. , 1992, Journal of the National Cancer Institute. Monographs.

[13]  M. Green,et al.  The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed? , 1999, Chest.

[14]  S. Oikawa,et al.  Molecular cloning of a gene for a member of carcinoembryonic antigen (CEA) gene family; signal peptide and N-terminal domain sequences of nonspecific crossreacting antigen (NCA). , 1987, Biochemical and biophysical research communications.

[15]  S. Phillips,et al.  Amino-acid and cDNA nucleotide sequences of human Clara cell 10 kDa protein. , 1988, Biochimica et Biophysica Acta.

[16]  L. Liotta,et al.  General mechanisms of metastasis , 1997, Cancer.

[17]  S. Oikawa,et al.  Primary structure of nonspecific crossreacting antigen (NCA), a member of carcinoembryonic antigen (CEA) gene family, deduced from cDNA sequence. , 1988, Biochemical and biophysical research communications.

[18]  S. Morinaga,et al.  Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system , 2004, Virchows Archiv.

[19]  T. Pilot‐Matias,et al.  Two SP-C genes encoding human pulmonary surfactant proteolipid. , 1988, The Journal of biological chemistry.

[20]  I. Fidler,et al.  Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.

[21]  J. Shih,et al.  Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. , 1998, Cancer research.

[22]  S. Abe,et al.  Assessment of differentiation in adenocarcinoma cells from pleural effusion by peripheral airway cell markers and their diagnostic values. , 2002, Lung cancer.

[23]  B. Corrin,et al.  Oat‐cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid , 1968, Cancer.

[24]  H. Müller-Hermelink,et al.  Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptase-polymerase chain reaction. , 1995, Cancer research.

[25]  T. Nakajima,et al.  Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors: Special reference to nonmucus producing lung adenocarcinomas , 1988, Cancer.

[26]  A. Malkinson,et al.  The Role of CC10 in Pulmonary Carcinogenesis: From a Marker to Tumor Suppression , 2000, Annals of the New York Academy of Sciences.

[27]  M. Neumaier,et al.  Diagnosis of micrometastases by the amplification of tissue-specific genes. , 1995, Gene.

[28]  M. Neumaier,et al.  Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes , 1999, British Journal of Cancer.

[29]  F Graziano,et al.  Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. , 2001, Cancer research.

[30]  R. Folz,et al.  Surfactant Protein A: regulation of innate and adaptive immune responses in lung inflammation. , 2001, American journal of respiratory cell and molecular biology.

[31]  S. Abe,et al.  Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance. , 1995, Respiration; international review of thoracic diseases.

[32]  E. Crouch.  Collectins and pulmonary host defense. , 1998, American journal of respiratory cell and molecular biology.

[33]  S. Steinberg,et al.  Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. , 1992, American journal of clinical pathology.

[34]  A. Riggs,et al.  Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen. , 1988, The Journal of biological chemistry.

[35]  J. Polak,et al.  Polypeptide hormone production by “Carcinoid” apudomas and their relevant cytochemistry , 1974, Virchows Archiv. B, Cell pathology.

[36]  J. Schilling,et al.  Isolation and characterization of the human pulmonary surfactant apoprotein gene , 1985, Nature.

[37]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[38]  A. Gazdar,et al.  Peripheral airway cell differentiation in human lung cancer cell lines. , 1990, Cancer research.

[39]  D. Voelker,et al.  Epitope mapping for monoclonal antibodies identifies functional domains of pulmonary surfactant protein A that interact with lipids. , 1994, The Journal of biological chemistry.